1. PET‐DRIVEN RADIOTHERAPY IN PATIENTS WITH LOW RISK DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): THE DLCL10 MULTICENTER PHASE 2 TRIAL BY FONDAZIONE ITALIANA LINFOMI (FIL). (12th June 2019) Authors: Balzarotti, M.; Ricardi, U.; Spina, M.; Monagheddu, C.; Tucci, A.; Cavallo, F.; Zanni, M.; Arcari, A.; Rusconi, C.; Sartori, R.; Merli, F.; Re, F.; Vitolo, U.; Dessi, D.; Melis, L.; Gaidano, G.; Chiti, A.; Deidda, M.; Santoro, A.; Ciccone, G. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IMPACT OF PET IMAGING AND HISTOLOGIC TRANSFORMATION ON THE PROGNOSIS OF EARLY DISEASE PROGRESSION IN FOLLICULAR LYMPHOMA. (12th June 2019) Authors: Batlevi, C.L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Hamlin, P.; Horwitz, S.M.; Kumar, A.; Matasar, M.; Moskowitz, A.J.; Moskowitz, C.H.; Noy, A.; Palomba, M.L.; Portlock, C.; Straus, D.; Boccomini, C.; Tucci, A.; Zelenetz, A.D.; Seshan, V.E. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THE ELDERLY PROJECT BY THE FONDAZIONE ITALIANA LINFOMI: A PROSPECTIVE COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) OF 1353 ELDERLY PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA. (12th June 2019) Authors: Spina, M.; Merli, F.; Puccini, B.; Cavallo, F.; Cabras, M.G.; Fabbri, A.; Angrilli, F.; Zilioli, V.R.; Marino, D.; Balzarotti, M.; Ladetto, M.; Cox, M.C.; Petrucci, L.; Arcari, A.; Gini, G.; Chiappella, A.; Hohaus, S.; Musuraca, G.; Merli, M.; Sartori, R. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. LENALIDOMIDE AND RITUXIMAB (ReRi) AS FRONT LINE THERAPY OF ELDERLY FRAIL PATIENTS WITH DIFFUSE LARGE B‐CELLS LYMPHOMA. FIRST PLANNED INTERIM ANALYSIS OF A PHASE II STUDY OF THE FONDAZIONE ITALIANA LINFOMI (FIL). (12th June 2019) Authors: Gini, G.; Tani, M.; Bassan, R.; Tucci, A.; Ballerini, F.; Sampaolo, M.; Merli, F.; Re, F.; Annibali, O.; Liberati, A.; Visco, C.; Arcari, A.; Storti, S.; Fabbri, A.; Musuraca, G.; Zilioli, V.; Cox, M.; Luminari, S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. RESPONSE ORIENTED MAINTENANCE THERAPY IN ADVANCED FOLLICULAR LYMPHOMA. RESULTS OF THE INTERIM ANALYSIS OF THE FOLL12 TRIAL CONDUCTED BY THE FONDAZIONE ITALIANA LINFOMI. (12th June 2019) Authors: Federico, M.; Mannina, D.; Versari, A.; Ferrero, S.; Marcheselli, L.; Boccomini, C.; Dondi, A.; Tucci, A.; Guerra, L.; Galimberti, S.; Cavallo, F.; Olivieri, J.; Corradini, P.; Arcaini, L.; Chauvie, S.; Del Giudice, I.; Rusconi, C.; Pinto, A.; Molinari, A.; Pulsoni, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OBINUTUZUMAB‐MINICHOP FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA. A STUDY OF THE FONDAZIONE ITALIANA LINFOMI. (June 2017) Authors: Merli, F.; Luminari, S.; Salvi, F.; Cavallo, F.; Gini, G.; Musuraca, G.; Gaidano, G.; Cellini, C.; Merli, M.; Ferrari, A.; Molinari, A.; Liberati, A.M.; Conconi, A.; Matteucci, P.; Pozzi, S.; Musso, M.; Mammi, C.; Monaco, F.; Ferrero, S.; Tucci, A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PB2132: COPANLISIB PLUS RITUXIMAB-BENDAMUSTINE FOR RELAPSED-REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RECRUITMENT UPDATE ON AN ONGOING PHASE II TRIAL OF THE FONDAZIONE ITALIANA LINFOMI (FIL_COPA-RB). (23rd June 2022) Authors: Novo, M.; Castellino, A.; Chiappella, A.; Ciccone, G.; Balzarotti, M.; Arcari, A.; Scarpa, E.; Tucci, A.; Di Renzo, N.; Tarantini, G.; Gini, G.; Moretti, M.; Mannina, D.; Di Rocco, A.; Spina, M.; Vitolo, U. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 2003 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P1463: PHASE I DOSE ESCALATION OF LAVA-051, A NOVEL BISPECIFIC GAMMA-DELTA T-CELL ENGAGER (GAMMABODY™), IN RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES. (23rd June 2022) Authors: Broijl, A.; van de Donk, N.; Bosch, F.; Mateos, M. V.; Rodriguez-Otero, P.; Tucci, A.; Ghia, P.; Adang, A.; Parren, P.; Tuinhof, I.; Umarale, S.; Winograd, B.; van der Vliet, H.; Kater, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P1144: RADIOIMMUNOTHERAPY (RIT) VERSUS AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION (ASCT) IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA: A FONDAZIONE ITALIANA LINFOMI (FIL) PHASE III TRIAL. (23rd June 2022) Authors: Ladetto, M.; Tavarozzi, R.; Evangelista, A.; Zanni, M.; Tucci, A.; Anastasia, A.; Botto, B.; Boccomini, C.; Bolis, S.; Volpetti, S.; Zilioli, V. R.; Puccini, B.; Arcari, A.; Pavone, V.; Gaidano, G.; Corradini, P.; Tani, M.; Ferrero, S.; Cavallo, F.; Milone, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1032 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S244: EFFECT OF ANTI-SPIKE NEUTRALIZING MONOCLONAL ANTIBODIES ON COVID-19 PROGRESSION AND TIME TO VIRAL CLEARANCE IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND SARS-COV-2 INFECTION: THE GIMEMA EXPERIENCE. (23rd June 2022) Authors: Marasco, V.; Guidetti, A.; Piciocchi, A.; Candoni, A.; Bocchia, M.; Bruna, R.; Musto, P.; Visentin, A.; Turrini, M.; Tucci, A.; Selleri, C.; Crea, E.; Fazi, P.; Passamonti, F.; Corradini, P. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗